Macro Group Pharmaceuticals (Macro Capital) S.A.E Share Price
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
23/08/2026
|
5-day change | 1st Jan Change | ||
| 1.560 EGP | +2.63% |
|
+1.30% | +36.84% |
| 17/05 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 20/02 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 89Cr 1.75Cr 1.5Cr 1.41Cr 1.29Cr 2.43Cr 167.89Cr 2.45Cr 17Cr 6.47Cr 84Cr 6.58Cr 6.44Cr 278.94Cr | P/E 2026 * |
26x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 81Cr 1.6Cr 1.37Cr 1.28Cr 1.17Cr 2.21Cr 152.85Cr 2.23Cr 15Cr 5.89Cr 77Cr 5.99Cr 5.86Cr 253.94Cr | EV / Sales 2026 * |
0.68x | EV / Sales 2027 * | 0.5x |
| Free-Float |
30.46% | Yield 2026 * |
1.92% | Yield 2027 * | 2.56% |
| 1 day | +2.63% | ||
| 1 week | +1.30% | ||
| Current month | +4.70% | ||
| 1 month | +6.85% | ||
| 3 months | +27.87% | ||
| 6 months | +6.85% | ||
| Current year | +36.84% |
| 1 week | 1.44 |  | 1.59 |
| 1 month | 1.44 | | 1.74 |
| Current year | 1.02 | | 1.74 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
Tamir Saeed
BRD | Director/Board Member | - | 01/01/2021 |
Norbert Lurz
BRD | Director/Board Member | - | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.63% | +1.30% | -24.64% | -34.18% | 1.75Cr | |
| -0.75% | +5.19% | +78.98% | +127.10% | 1,11900Cr | |
| +0.90% | +3.83% | +52.70% | +65.02% | 65TCr | |
| -0.03% | +5.74% | +27.54% | +80.53% | 47TCr | |
| -1.38% | +4.02% | +42.52% | +42.38% | 37TCr | |
| -0.52% | +2.72% | +25.21% | +41.06% | 30TCr | |
| -1.06% | +4.76% | +2.00% | +12.65% | 26TCr | |
| +0.91% | +5.25% | +53.01% | +72.01% | 24TCr | |
| -0.53% | +2.34% | -18.53% | -53.66% | 21TCr | |
| +0.29% | +5.42% | +28.30% | +91.86% | 18TCr | |
| Average | +0.01% | +4.92% | +26.71% | +44.48% | 38TCr | |
| Weighted average by Cap. | -0.32% | +5.40% | +45.66% | +72.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 119Cr 2.35Cr 2.01Cr 1.88Cr 1.72Cr 3.24Cr 224.61Cr 3.28Cr 22Cr 8.65Cr 112.78Cr 8.81Cr 8.62Cr 373.16Cr | 155.2Cr 3.06Cr 2.62Cr 2.45Cr 2.24Cr 4.23Cr 292.93Cr 4.28Cr 29Cr 11Cr 147.09Cr 11Cr 11Cr 486.68Cr |
| Net income | 21Cr 40.61L 34.8L 32.56L 29.76L 56.17L 39Cr 56.76L 3.85Cr 1.5Cr 20Cr 1.52Cr 1.49Cr 65Cr | 28Cr 55.78L 47.81L 44.72L 40.89L 77.16L 53Cr 77.98L 5.29Cr 2.06Cr 27Cr 2.09Cr 2.05Cr 89Cr |
| Net Debt | -7.97Cr -15.71L -13.46L -12.6L -11.52L -21.73L -15Cr -21.96L -1.49Cr -57.95L -7.55Cr -58.99L -57.71L -25Cr | -11Cr -21.68L -18.58L -17.38L -15.89L -29.99L -21Cr -30.31L -2.06Cr -79.99L -10Cr -81.41L -79.65L -34Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | EGP 1.560 | +2.63% | 5,93,15,818 |
| 20/26/20 | EGP 1.520 | +2.70% | 6,60,88,753 |
| 19/26/19 | EGP 1.480 | -1.99% | 4,58,63,966 |
| 18/26/18 | EGP 1.510 | -0.66% | 3,38,81,467 |
| 17/26/17 | EGP 1.520 | -1.30% | 6,94,65,046 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.560EGP
Average target price
1.570EGP
Spread / Average Target
+0.64%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
